| Identification | Back Directory | [Name]
Carbonic acid, [[(6aR,7S,10R)-6-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-2,6,6a,7,10,12-hexahydro-2,12-dioxo-7,10-methanodipyrido[2,1-c:2',1'-f][1,2,4]triazin-1-yl]oxy]methyl methyl ester | [CAS]
2454680-16-9 | [Synonyms]
Cap-dependent endonuclease-IN-8
Carbonic acid, [[(6aR,7S,10R)-6-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-2,6,6a,7,10,12-hexahydro-2,12-dioxo-7,10-methanodipyrido[2,1-c:2',1'-f][1,2,4]triazin-1-yl]oxy]methyl methyl ester | [Molecular Formula]
C29H23F2N3O6S | [MOL File]
2454680-16-9.mol | [Molecular Weight]
579.57 |
| Hazard Information | Back Directory | [Uses]
Cap-dependent endonuclease-IN-8 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-8 inhibits replication of orthomyxoviruses (including influenza A, influenza B and influenza C) (extracted from patent CN111410661A, compound I-196)[1]. | [References]
[1] Yutian Zhou, et al. Cap-dependent endonuclease inhibitor and use thereof. Patent CN111410661A. |
|
|